(M) Macy’s - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US55616P1049
Apparel, Accessories, Cosmetics, Home, Consumer Goods
Dividends
| Dividend Yield | 4.00% |
| Yield on Cost 5y | 9.61% |
| Yield CAGR 5y | 16.49% |
| Payout Consistency | 90.3% |
| Payout Ratio | 30.9% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 48.6% |
| Value at Risk 5%th | 65.4% |
| Relative Tail Risk | -18.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.88 |
| Alpha | 25.77 |
| CAGR/Max DD | 0.11 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.452 |
| Beta | 1.468 |
| Beta Downside | 1.297 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.31% |
| Mean DD | 28.96% |
| Median DD | 30.76% |
Description: M Macy’s November 08, 2025
Macy’s, Inc. (NYSE:M) is an omni-channel retailer operating department-store formats, e-commerce sites, and mobile apps across the United States under the Macy’s, Bloomingdale’s, and Bluemercury brands, with licensed stores in Dubai and Kuwait. Founded in 1830 and headquartered in New York, the firm transitioned from Federated Department Stores to its current name in 2007 and now competes in the Broadline Retail sub-industry.
Key recent metrics (FY 2023): comparable sales fell 1.8% YoY, while e-commerce sales grew 9.5% and now represent roughly 30% of total revenue; inventory turnover improved to 4.2×, reflecting tighter supply-chain management. The business is sensitive to consumer-discretionary spending, which is currently constrained by elevated inflation and higher interest rates that depress discretionary purchases and foot traffic in malls.
For a deeper, data-driven view of Macy’s valuation and risk profile, you might explore the analyst tools available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (478.0m TTM) > 0 and > 6% of Revenue (6% = 1.36b TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 5.07pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 6.59% (prev 6.30%; Δ 0.29pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 1.55b > Net Income 478.0m (YES >=105%, WARN >=100%) |
| Net Debt (4.80b) to EBITDA (1.62b) ratio: 2.96 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.25 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (274.6m) change vs 12m ago -2.45% (target <= -2.0% for YES) |
| Gross Margin 40.38% (prev 40.86%; Δ -0.48pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 132.2% (prev 135.2%; Δ -2.95pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.37 (EBITDA TTM 1.62b / Interest Expense TTM 98.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.60
| (A) 0.09 = (Total Current Assets 7.38b - Total Current Liabilities 5.89b) / Total Assets 17.06b |
| (B) 0.38 = Retained Earnings (Balance) 6.50b / Total Assets 17.06b |
| (C) 0.04 = EBIT TTM 722.0m / Avg Total Assets 17.18b |
| (D) 0.48 = Book Value of Equity 6.05b / Total Liabilities 12.74b |
| Total Rating: 2.60 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 52.70
| 1. Piotroski 5.50pt |
| 2. FCF Yield 10.15% |
| 3. FCF Margin 4.79% |
| 4. Debt/Equity 1.21 |
| 5. Debt/Ebitda 2.96 |
| 6. ROIC - WACC (= 0.68)% |
| 7. RoE 10.75% |
| 8. Rev. Trend -39.42% |
| 9. EPS Trend -57.58% |
What is the price of M shares?
As of December 10, 2025, the stock is trading at USD 22.57 with a total of 5,131,858 shares traded.
Over the past week, the price has changed by -0.62%, over one month by +9.72%, over three months by +32.57% and over the past year by +41.96%.
Over the past week, the price has changed by -0.62%, over one month by +9.72%, over three months by +32.57% and over the past year by +41.96%.
Is M a buy, sell or hold?
Macy’s has received a consensus analysts rating of 3.15.
Therefor, it is recommend to hold M.
- Strong Buy: 2
- Buy: 0
- Hold: 10
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the M price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19.9 | -12% |
| Analysts Target Price | 19.9 | -12% |
| ValueRay Target Price | 26.4 | 16.9% |
M Fundamental Data Overview December 06, 2025
Market Cap USD = 5.91b (5.91b USD * 1.0 USD.USD)
P/E Trailing = 13.1294
P/E Forward = 12.8535
P/S = 0.2603
P/B = 1.3747
P/EG = 2.5691
Beta = 1.476
Revenue TTM = 22.71b USD
EBIT TTM = 722.0m USD
EBITDA TTM = 1.62b USD
Long Term Debt = 2.43b USD (from longTermDebt, last quarter)
Short Term Debt = 6.00m USD (from shortTermDebt, last fiscal year)
Debt = 5.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.80b USD (from netDebt column, last quarter)
Enterprise Value = 10.71b USD (5.91b + Debt 5.24b - CCE 447.0m)
Interest Coverage Ratio = 7.37 (Ebit TTM 722.0m / Interest Expense TTM 98.0m)
FCF Yield = 10.15% (FCF TTM 1.09b / Enterprise Value 10.71b)
FCF Margin = 4.79% (FCF TTM 1.09b / Revenue TTM 22.71b)
Net Margin = 2.10% (Net Income TTM 478.0m / Revenue TTM 22.71b)
Gross Margin = 40.38% ((Revenue TTM 22.71b - Cost of Revenue TTM 13.54b) / Revenue TTM)
Gross Margin QoQ = 41.89% (prev 41.99%)
Tobins Q-Ratio = 0.63 (Enterprise Value 10.71b / Total Assets 17.06b)
Interest Expense / Debt = 0.48% (Interest Expense 25.0m / Debt 5.24b)
Taxrate = -120.0% (out of range, set to none) (-6.00m / 5.00m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.25 (Total Current Assets 7.38b / Total Current Liabilities 5.89b)
Debt / Equity = 1.21 (Debt 5.24b / totalStockholderEquity, last quarter 4.33b)
Debt / EBITDA = 2.96 (Net Debt 4.80b / EBITDA 1.62b)
Debt / FCF = 4.41 (Net Debt 4.80b / FCF TTM 1.09b)
Total Stockholder Equity = 4.45b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.80% (Net Income 478.0m / Total Assets 17.06b)
RoE = 10.75% (Net Income TTM 478.0m / Total Stockholder Equity 4.45b)
RoCE = 10.50% (EBIT 722.0m / Capital Employed (Equity 4.45b + L.T.Debt 2.43b))
RoIC = 6.73% (EBIT 722.0m / (Assets 17.06b - Curr.Liab 5.89b - Cash 447.0m))
WACC = 6.05% (E(5.91b)/V(11.16b) * Re(11.42%) + (debt cost/tax rate unavailable))
Discount Rate = 11.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.54%
[DCF Debug] Terminal Value 66.82% ; FCFE base≈741.8m ; Y1≈737.7m ; Y5≈774.0m
Fair Price DCF = 31.15 (DCF Value 8.25b / Shares Outstanding 264.9m; 5y FCF grow -1.25% → 3.0% )
EPS Correlation: -57.58 | EPS CAGR: -58.57% | SUE: 1.47 | # QB: 1
Revenue Correlation: -39.42 | Revenue CAGR: -14.73% | SUE: 1.49 | # QB: 4
EPS next Quarter (2026-04-30): EPS=0.15 | Chg30d=+0.005 | Revisions Net=+0 | Analysts=6
EPS next Year (2027-01-31): EPS=2.14 | Chg30d=+0.126 | Revisions Net=+3 | Growth EPS=+2.0% | Growth Revenue=-3.7%
P/E Trailing = 13.1294
P/E Forward = 12.8535
P/S = 0.2603
P/B = 1.3747
P/EG = 2.5691
Beta = 1.476
Revenue TTM = 22.71b USD
EBIT TTM = 722.0m USD
EBITDA TTM = 1.62b USD
Long Term Debt = 2.43b USD (from longTermDebt, last quarter)
Short Term Debt = 6.00m USD (from shortTermDebt, last fiscal year)
Debt = 5.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.80b USD (from netDebt column, last quarter)
Enterprise Value = 10.71b USD (5.91b + Debt 5.24b - CCE 447.0m)
Interest Coverage Ratio = 7.37 (Ebit TTM 722.0m / Interest Expense TTM 98.0m)
FCF Yield = 10.15% (FCF TTM 1.09b / Enterprise Value 10.71b)
FCF Margin = 4.79% (FCF TTM 1.09b / Revenue TTM 22.71b)
Net Margin = 2.10% (Net Income TTM 478.0m / Revenue TTM 22.71b)
Gross Margin = 40.38% ((Revenue TTM 22.71b - Cost of Revenue TTM 13.54b) / Revenue TTM)
Gross Margin QoQ = 41.89% (prev 41.99%)
Tobins Q-Ratio = 0.63 (Enterprise Value 10.71b / Total Assets 17.06b)
Interest Expense / Debt = 0.48% (Interest Expense 25.0m / Debt 5.24b)
Taxrate = -120.0% (out of range, set to none) (-6.00m / 5.00m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.25 (Total Current Assets 7.38b / Total Current Liabilities 5.89b)
Debt / Equity = 1.21 (Debt 5.24b / totalStockholderEquity, last quarter 4.33b)
Debt / EBITDA = 2.96 (Net Debt 4.80b / EBITDA 1.62b)
Debt / FCF = 4.41 (Net Debt 4.80b / FCF TTM 1.09b)
Total Stockholder Equity = 4.45b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.80% (Net Income 478.0m / Total Assets 17.06b)
RoE = 10.75% (Net Income TTM 478.0m / Total Stockholder Equity 4.45b)
RoCE = 10.50% (EBIT 722.0m / Capital Employed (Equity 4.45b + L.T.Debt 2.43b))
RoIC = 6.73% (EBIT 722.0m / (Assets 17.06b - Curr.Liab 5.89b - Cash 447.0m))
WACC = 6.05% (E(5.91b)/V(11.16b) * Re(11.42%) + (debt cost/tax rate unavailable))
Discount Rate = 11.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.54%
[DCF Debug] Terminal Value 66.82% ; FCFE base≈741.8m ; Y1≈737.7m ; Y5≈774.0m
Fair Price DCF = 31.15 (DCF Value 8.25b / Shares Outstanding 264.9m; 5y FCF grow -1.25% → 3.0% )
EPS Correlation: -57.58 | EPS CAGR: -58.57% | SUE: 1.47 | # QB: 1
Revenue Correlation: -39.42 | Revenue CAGR: -14.73% | SUE: 1.49 | # QB: 4
EPS next Quarter (2026-04-30): EPS=0.15 | Chg30d=+0.005 | Revisions Net=+0 | Analysts=6
EPS next Year (2027-01-31): EPS=2.14 | Chg30d=+0.126 | Revisions Net=+3 | Growth EPS=+2.0% | Growth Revenue=-3.7%
Additional Sources for M Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle